At a glance:
- New journal aims to generate evidence for medical uses of AI
- Properly evaluated AI tools can help inform clinical and regulatory decision-making, which ultimately benefits patients
- HMS experts to steer new AI journal as part of journey to transform the field of clinical AI
Isaac Kohane, founding chair of the Department of Biomedical Informatics (DBMI) in the Blavatnik Institute at Harvard Medical School, will be the inaugural editor-in-chief of NEJM AI, the new AI-themed journal from NEJM Group, the publisher of the New England Journal of Medicine.
The mission of the new journal is to generate and publish rigorous evidence to help researchers, clinicians, health care leaders and policymakers in their efforts to harness the promise of AI to transform medicine. The content will aim to illuminate some of the most critical questions in the field of clinical AI by analyzing emerging evidence in a manner that can help inform clinical and regulatory decision-making.
“The field of AI has reached a crucial inflection point, and medicine can reap tremendous benefits from advances in machine learning and artificial intelligence, as long as these advances are harnessed in an evidence-based, informed, safe, and ethical manner,” said Kohane. “The goal of NEJM AI is to help inform the field to do just that.